Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06067295

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Prostate Carcinoma Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Los Angeles General Medical Center, Los Angeles, California, United States

Loading trial locations.

About this study

PRIMARY OBJECTIVE:

I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.

OUTLINE: This is an observational study.

Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men of all racial and ethnic groups 18 years of age or older
  • Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
  • Prior participation on clinical trials is allowed

Exclusion criteria

  • Inability to give informed consent
  • Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer

Treatment and study plan

Non-Interventional Study

Other

Non-interventional study

Primary outcomes

  1. Collection of biological specimens and clinical data for future research related to prostate cancer.

    Time frame: Up to 5 years

    The objective of this study is to create a biorepository of biospecimen and clinical data. There is no primary clinical outcome for this study.

Study contacts

Contact information is provided by the study sponsor or research team.

Cheryl Kefauver, RN

CONTACT

[email protected]

323-865-0459

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Oct 4, 2023
Registry last updated
Mar 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.